Delivery Order SPE2DB24D9801-SPE2DB25FKXYM
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price delivery order, valued at $10,511.40, is set to be completed by April 25, 2025, and will be performed at the contractor's Park Ridge location. The award carries no set-aside designation, indicating DMS...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Jardiance 25 mg tablets. The order has a potential value of $4,094.64 and is set to be completed by February 9, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that holds an indefinite delivery contract with the Defense Logistics Agency, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $30,010.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 10 mg tablets in quantities of 90. The contract employs a firm fixed-price structure with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $17.8K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 25 mg tablets (90-count units). The delivery order, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, carries no set-aside designation. This award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $4.7 million to DMS Pharmaceutical Group Inc. for 90-count tablets of Jardiance 25 mg, a diabetes medication. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,047.32 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,162.08 to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets (90-count packages). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery to Conshohocken, Pennsylvania by the August 22, 2025 completion date. This delivery order was awarded without set-aside designation and represents a continuation of DMS...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,654.30 firm fixed-price contract is for the delivery of Jardiance 25 mg tablets in 90-count packages. The contract has a completion date of July 2, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $2,047.32 under the Defense Logistics Agency Troop Support Medical indefinite delivery contract to supply 90 JARDIANCE 10 MG tablets. The place of performance is Park Ridge, Illinois and the completion date is December 11, 2023. As a woman-owned small business, DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications...
- The Defense Logistics Agency awarded a delivery order valued at $31,518.19 to DMS Pharmaceutical Group Inc. for 90 tablets of Jardiance 25 mg, a diabetes medication. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive...
- SPE2DB24D9801Indefinite Delivery Contract
- SPE2DB24D9801-SPE2DB25FKXYMDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,255.70 by the Defense Logistics Agency (DLA) on April 24, 2025. The contract calls for the supply of Jardiance 10 mg tablets in a 90-count package, with completion scheduled for April 25, 2025. This delivery order was issued without a set-aside designation and is performed at the contractor's facility in Park Ridge, Illinois. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026. The parent IDC, administered under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products to support Department of Defense medical supply requirements at military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a significant supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to consistently compete for and secure contracts across diverse medication categories ranging from specialty oncology treatments to routine pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 4/24/25 |